ArticleScientific reports2026
Microwave assisted synthesis and antimicrobial evaluation of novel Thiazolidinedione pyrrole hybrids with antiviral potential and comprehensive computational modeling studies.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
A novel class of N-substituted thiazolidine-2,4-dione/pyrrole-2,5-dione moiety derivatives 3(a–g) was synthesized via C–N bond formation through SN2-mediated reaction, utilizing microwave-assisted synthesis to enhance reaction efficiency and product yield. This approach enabled the rapid and selective formation of the target compounds, which were evaluated for their in vitro antimicrobial activity against a variety of bacterial and fungal strains. The compounds demonstrated promising antibacterial and antifungal properties, with compound 3g showing the highest activity, producing significant inhibition zones against Gram-negative strains (E. coli and P. aeruginosa) as well as Gram-positive strains (S. aureus and B. subtilis). To further validate and refine the docking outcomes, molecular dynamics (MD) simulations were performed, providing detailed insights into the dynamic stability, conformational adaptability, hydrogen-bond persistence, and overall binding energetics of the most promising ligand–protein complexes. Density functional theory (DFT) calculations provided valuable insights into the electronic properties, stability, and reactivity of the compounds. The study successfully identified targeted compounds exhibiting significant antiviral/anti–SARS-CoV-2 potential using the pharmacophore POM model, highlighting their predicted ability to inhibit crucial viral proteins. The structures of the synthesized compounds were confirmed using a range of spectroscopic techniques, including FT IR, 1H NMR, 13C NMR, and mass spectrometry, ensuring the successful synthesis of the bioactive derivatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.